Log in

LON:RER.E.A. Share Price, Forecast & News

GBX 56.50
+1.00 (+1.80 %)
(As of 05/29/2020 06:58 AM ET)
Add
Compare
Today's Range
55
Now: GBX 56.50
56.50
50-Day Range
49
MA: GBX 72.56
98.50
52-Week Range
25
Now: GBX 56.50
186
Volume5,600 shs
Average Volume1,621 shs
Market Capitalization£24.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
R.E.A. Holdings plc cultivates oil palms in the province of East Kalimantan in Indonesia. The company also produces and sells crude palm oil and crude palm kernel oil. As of December 31, 2017, its planted area comprised approximately 44,094 hectares. In addition, the company is involved in stone quarrying and coal mining activities. It holds interests in two stone deposits and two coal mining concessions located in East Kalimantan. The company also generates renewable energy from its methane capture plants. R.E.A. Holdings plc was founded in 1906 and is based in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry Farm Products
Sub-IndustryN/A
SectorConsumer Goods
CUSIPN/A
CIKN/A
Phone+44-20-74190100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£124.99 million
Cash FlowGBX 25.29 per share
Book ValueGBX 568.60 per share

Profitability

Miscellaneous

Employees10,958
Market Cap£24.76 million
Next Earnings DateN/A
OptionableOptionable

Receive RE News and Ratings via Email

Sign-up to receive the latest news and ratings for RE and its competitors with MarketBeat's FREE daily newsletter.

R.E.A. (LON:RE) Frequently Asked Questions

How has R.E.A.'s stock been impacted by COVID-19 (Coronavirus)?

R.E.A.'s stock was trading at GBX 107.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RE stock has decreased by 47.4% and is now trading at GBX 56.50. View which stocks have been most impacted by Coronavirus.

Has R.E.A. been receiving favorable news coverage?

Media stories about RE stock have trended very negative this week, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. R.E.A. earned a daily sentiment score of -3.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutR.E.A..

Who are some of R.E.A.'s key competitors?

What other stocks do shareholders of R.E.A. own?

Who are R.E.A.'s key executives?

R.E.A.'s management team includes the following people:
  • Ms. Carol E. Gysin, MD & Exec. Director (Age 61)

What is R.E.A.'s stock symbol?

R.E.A. trades on the London Stock Exchange (LON) under the ticker symbol "RE."

How do I buy shares of R.E.A.?

Shares of RE and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is R.E.A.'s stock price today?

One share of RE stock can currently be purchased for approximately GBX 56.50.

How big of a company is R.E.A.?

R.E.A. has a market capitalization of £24.76 million and generates £124.99 million in revenue each year. R.E.A. employs 10,958 workers across the globe.

What is R.E.A.'s official website?

The official website for R.E.A. is www.rea.co.uk.

How can I contact R.E.A.?

R.E.A.'s mailing address is First Fl, 32-36 Great Portland Street, LONDON, W1W 8QX, United Kingdom. The company can be reached via phone at +44-20-74190100.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.